---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005359"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2025-04-18T23:59:59+00:00"
generated_at: "2026-05-23T10:56:41.937681+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INVO Fertility (fka NAYA) receives Nasdaq delisting notice for late 10-K; changes name to INVO Fertility

## Summary
- Received Nasdaq letter on April 16, 2025 for failure to file 2024 10-K on time; 60 days to submit compliance plan.
- If plan accepted, Nasdaq may grant exception until October 13, 2025 to regain compliance.
- Company expects to file the 10-K as soon as practicable.
- Effective April 14, 2025 changed name from NAYA Biosciences to INVO Fertility, Inc.; intends to trade under ticker 'IVF' on Nasdaq.

## SEC filing metadata
- accession: 0001641172-25-005359
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2025-04-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000164117225005359/0001641172-25-005359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000164117225005359/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005359
- JSON: https://secwatch.observer/filing/0001641172-25-005359.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005359.txt

## Key facts
- Listing & Compliance Notices
  INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: April 16, 2025, INVO Fertility, Inc. (the “Company”), formerly known as NAYA Biosciences, Inc., received a letter (the “Letter”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company failed to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Filing”), on a timely basis and, as such, no longer satisfies Nasdaq Listing Rule 5250(c)(1) (the “Rule”). The Letter has no immediate effect on the listing of the Company’s common stock and the Company’s common stock continues to trade on The Nasdaq Capital M
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000164117225005359/0001641172-25-005359-index.htm
- Governance Changes
  INVO Fertility, Inc.: Company changed its corporate name to INVO Fertility, Inc. via an Amendment to Articles of Incorporation filed with Nevada Secretary of State on April 14, 2025 (effective 2025-04-14).
  - Change: charter amendment
  - Effective: 2025-04-14
  source text: On April 14, 2025, the Company changed its corporate name to INVO Fertility, Inc., pursuant to an Amendment to Articles of Incorporation filed with the Nevada Secretary of State on April 14, 2025 (the “Name Change”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000164117225005359/0001641172-25-005359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.